Skip to main content
SpringerLink
Log in

Tumor progression: Potential role of unstable genomic changes

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

It is generally accepted that the genome of tumor cells is less stable than that of most normal cells, and it has been hypothesized that this genomic instability is probably involved in the process of tumor progression. However, the rate of occurrence of classical spontaneous mutations in tumor cells is too low to account for the rapid changes that can occur during tumor progression. Thus it is likely that other types of changes, such as gene amplification, must be involved in tumor progression. Gene amplification has been extensively studied in relation to the development of drug resistance. Low levels of amplification can occur spontaneously in tumor cell populations, but the amplified genes are lost rapidly unless prolonged selective pressure is applied. This paper argues that unstable increases in the expression of genes, probably as a result of low levels of amplification, may be all that is required for some of the stages in the process of tumor progression. This may be particularly true for the steps involved in metastasis formation. Recent studies have suggested that microenvironmental conditions known to occur in tumors (hypoxia, nutrient deprivation) may induce gene amplification in cells. This suggests the possibility that such conditions could promote tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Foulds L: The experimental study of tumor progression: A review. Cancer Res 14: 327–339, 1954

    Google Scholar 

  2. Foulds L: Neoplastic development. Academic Press, London, 1975

    Google Scholar 

  3. Sugarbaker EV: Patterns of metastasis in human malignancies. Cancer Biol Rev 2: 235–278, 1981

    Google Scholar 

  4. Plesnicar S: Mechanisms of development of metastases. Crit Rev Oncogenesis 1: 175–194, 1989

    Google Scholar 

  5. Nowell PC: The clonal evolution of tumor cell populations. Science 194: 23–28, 1976

    Google Scholar 

  6. Nowell PC: Mechanisms of tumor progression. Cancer Res 46: 2203–2207, 1986

    Google Scholar 

  7. Waghorne C, Thomas M, Lagarde A, Kerbel RS, Breitman ML: Genetic evidence for progressive selection and overgrowth of primary by metastatic cell subpopulations. Cancer Research 48: 6109–6114, 1988

    Google Scholar 

  8. Kerbel RS, Waghorne C, Korczak B, Lagarde A, Breitman ML: Clonal dominance of primary tumours by metastatic cells: Genetic analysis and biological implications. Cancer Surveys 7: 597–629, 1988

    Google Scholar 

  9. Nicolson GL: Cancer metastasis: Organ colonization and the cell surface properties of malignant cells. Biochim Biophys Acta 695: 113–176, 1982

    Google Scholar 

  10. Schirrmacher V: Cancer metastasis: Experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res 43: 1–73, 1985

    Google Scholar 

  11. Ling V, Chambers AF, Harris JF, Hill RP: Quantitative genetic analysis of tumor progression. Cancer Met Reviews 4: 173–194, 1985

    Google Scholar 

  12. Stark GR: DNA amplification in drug resistant cells and in tumours. Cancer Surveys 5: 1–23, 1986

    Google Scholar 

  13. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 47: 1473–1487, 1987

    Google Scholar 

  14. Volpe JPG: Genetic instability of cancer: Why a metastatic tumor is unstable and a benign tumor is stable. Cancer Genet Cytogenet 34: 125–134, 1988

    Google Scholar 

  15. Kendal WS and Frost P: Genetic instability and tumor progression. Pathol Immunopathol Res 5: 455–467, 1986

    Google Scholar 

  16. Nowell PC: Chromosomal and molecular clues to tumor progression. Seminars in Oncology 16: 116–127, 1989

    Google Scholar 

  17. Sager R: Tumor suppressor genes: the puzzle and the promise. Science 246: 1406–1412, 1989

    Google Scholar 

  18. Cifone MA, Fidler IJ: Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 78: 6949–6952, 1981

    Google Scholar 

  19. Elmore E, Kakunaga T, Barrett JC: Comparison of spontaneous mutation rates of normal and chemically transformed human skin fibroblasts. Cancer Res 43: 1650–1655, 1983

    Google Scholar 

  20. Yamashina K, Heppner GH: Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor. Cancer Res 45: 4015–4019, 1985

    Google Scholar 

  21. Kendal WS, Frost P: Metastatic potential and spontaneous mutation rates: studies with 2 murine cell lines and their recently induced metastatic variants. Cancer Res 46: 6131–6135, 1986

    Google Scholar 

  22. Sager R, Gadi IK, Stephens L, Grabowy CT: Gene amplification: An example of accelerated evolution in tumorigenic cells. Proc Natl Acad Sci USA 82: 7015–7019, 1985

    Google Scholar 

  23. Cillo C, Dick JE, Ling V, Hill RP: Generation of drug-resistance variants in metastatic B16 mouse melanoma cell lines. Cancer Res 47: 2604–2608, 1987

    Google Scholar 

  24. Tlsty TD, Margolin BH, Lum K: Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. Proc Natl Acad Sci USA 86: 9441–9445, 1989

    Google Scholar 

  25. Otto E, McCord S, Tlsty TD: Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells. J Biol Chemistry 264: 3390–3395, 1989

    Google Scholar 

  26. Alitalo K, Schwarb M: Oncogene amplification in tumor cells. Advances in Cancer Research 47: 235–259, 1986

    Google Scholar 

  27. Garte SJ, Burns FJ, Ashkenazi-Kimmel T, Cosma GN, Sawey MJ: An experimental model for oncogene activation during tumor progression in vivo. Anticancer Res 9: 1439–1446, 1989

    Google Scholar 

  28. Wright JA, Smith HS, Watt FM, Hancock MC, Hudson DL, Stark GR: DNA amplification is rare in normal human cells. Proc Natl Acad Sci USA 87: 1791–1795, 1990

    Google Scholar 

  29. Fukumoto M, Shevrin DH, Roninson IB: Analysis of gene amplification in human tumor cell lines. Proc Natl Acad Sci USA 85: 6846–6850, 1988

    Google Scholar 

  30. Stark GR, Debatisse M, Giulotto E, Wahl GM: Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57: 901–908, 1989

    Google Scholar 

  31. Wahl GM: The importance of circular DNA in mammalian gene amplification. Cancer Res 49: 1333–1340, 1989

    Google Scholar 

  32. Schimke RT: Gene amplification in cultured cells. J Biol Chem 263: 5989–5992, 1988

    Google Scholar 

  33. Heppner GH: Tumor heterogeneity. Cancer Res 44: 2259–2265, 1984

    Google Scholar 

  34. Johnston RN, Beverley SM, Schimke RT: Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting. Proc Natl Acad Sci USA 80: 3711–3715, 1983

    Google Scholar 

  35. Weiss L: Metastatic inefficiency. Advances in Cancer Research 54: 159–211, 1990

    Google Scholar 

  36. Buckley ND, Carlsen SA: Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma. Cancer Res 48: 1451–1455, 1988

    Google Scholar 

  37. Carlsen SA, Barry M, Newton K: The identification of a neutral glycosphingolipid antigenic marker for metastatic cells in the R3230AC rat mammary adenocarcinoma. Clin Expl Metastasis 8: 141–151, 1990

    Google Scholar 

  38. Dennis JW, Laferté S, Waghorne C, Breitman ML, Kerbel RS: β1–6 branching of an Asn-linked oligosaccharide is directly associated with metastasis. Science 236: 582–585, 1987

    Google Scholar 

  39. Yagel S, Feinmesser R, Waghorne C, Lala PK, Breitman ML, Dennis JW: Evidence that beta 1–6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int J Cancer 44: 685–690, 1989

    Google Scholar 

  40. Hart IR: The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol 97: 587–600, 1979

    Google Scholar 

  41. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA: Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 2: 55–59, 1987

    Google Scholar 

  42. Hill SA, Wilson S, Chambers AF: Clonal heterogeneity, experimental metastatic ability and p21 expression in H-ras-transformed NIH-3T3 cells. J Natl Cancer Inst 7: 484–490, 1988

    Google Scholar 

  43. Nagy B, Grdina DJ: Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma. Clin Expl Metastasis 7: 243–250, 1989

    Google Scholar 

  44. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Canc Inst 80: 200–204, 1988

    Google Scholar 

  45. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME: Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 48: 6550–6554, 1988

    Google Scholar 

  46. Dear NT, Ramshaw IA, Kefford RF: Differential expression of a novel gene, wdnml, in non-metastatic rat mammary adenocarcinoma cells. Cancer Res 48: 5203–5209, 1988

    Google Scholar 

  47. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185–5190, 1989

    Google Scholar 

  48. Shen D-W, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM: Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification. Science 232: 643–645, 1986

    Google Scholar 

  49. Young SD, Hill RP: Dynamic heterogeneity: isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype. Clin Expl Metastasis 4: 153–176, 1986

    Google Scholar 

  50. Bevacqua SJ, Greeff CW, Hendrix MJC: Cytogenetic evidence of gene amplification as a mechanism for tumor cell invasion. Somatic Cell and Molecular Genetics 14: 83–91, 1988

    Google Scholar 

  51. Fisher MS, Cifone MA: Enhanced metastatic potential of murine fibosarcoma cells treated in vitro with ultraviolet radiation. Cancer Res 41: 3018–3023, 1981

    Google Scholar 

  52. McMillan TJ, Hart IR: Enhanced experimental metastatic capacity of a murine melanoma following pretreatment with anticancer drugs. Clin Expl Metastasis 4: 285–292, 1986

    Google Scholar 

  53. Poupon M-F, Pauwels C, Jasmin C, Antoine E, Lascaux V, Rosa B: Amplified pulmonary metastases of a rat rhabdomyosarcoma in response to nitrosourea treatment. Cancer Treatment Reports 68: 749–758, 1984

    Google Scholar 

  54. Rice GC, Hoy C, Schimke RT: Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83: 5978–5982, 1986

    Google Scholar 

  55. Rice GC: Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (Adriamycin) resistance. Proc Natl Acad Sci USA 84: 9261–9264, 1987

    Google Scholar 

  56. Young SD, Marshall RS, Hill RP: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85: 9533–9537, 1988

    Google Scholar 

  57. Young SD, Hill RP: Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Canc Inst 82: 371–380, 1990

    Google Scholar 

  58. Branda RF, McCormack JJ, Perlmutter CA, Mathews LA, Robison SH: Effects of folate deficiency on the metastatic potential of murine melanoma cells. Cancer Res 48: 4529–4534, 1988

    Google Scholar 

  59. Anderson GR, Stoler DL, Scarcello LA. Normal fibroblasts responding to anoxia exhibit features of the malignant phenotype. J Biol Chemistry 264: 14885–14892, 1989

    Google Scholar 

  60. Luk CK, Veinot-Drebot L, Tjan E, Tannock IF: Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. J Natl Canc Inst 82: 684–692, 1990

    Google Scholar 

  61. Cillo C, Ling V, Hill RP: Drug resistance in KHT fibrosarcoma cell lines with different metastatic ability. Int J Cancer 43: 107–111, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ontaro Cancer Institute, University of Toronto, 500 Sherbourne Street, M4X 1K9, Toronto, Ontario, Canada

    R. P. Hill

  2. Dept. of Medical Biophysics, University of Toronto, 500 Sherbourne Street, M4X 1K9, Toronto, Ontario, Canada

    R. P. Hill

Authors
  1. R. P. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hill, R.P. Tumor progression: Potential role of unstable genomic changes. Cancer Metast Rev 9, 137–147 (1990). https://doi.org/10.1007/BF00046340

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00046340

Key words

Search

Navigation